Financial Gravity Asset Management, Inc. Protagonist Therapeutics, Inc Transaction History

Financial Gravity Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$21.79 - $32.15 $392 - $578	18 New	18 $522,000
Q2 2023 Aug 08, 2023	BUY	$18.02 - $29.36 $504 - $822	28 New	28 $470,000
Q4 2022 Feb 15, 2023	BUY	$7.36 - $11.17 $80 - $122	11 New	11 $197,000
Q1 2020 May 12, 2020	SELL	$5.4 - $9.22 $297 - $507	-55 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$5.99 - $9.1 $317 - $482	53 Added 2650.0%	55 $1,000
Q1 2018 May 23, 2018	BUY	$8.46 - $23.08 $16 - $46	2 New	2 $0

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.